At the end of the latest market close, NanoViricides Inc. (NNVC) was valued at $3.92. In that particular session, Stock kicked-off at the price of $4.15 while reaching the peak value of $5.85 and lowest value recorded on the day was $4.01. The stock current value is $5.58.
Recently in News on September 2, 2020, NanoViricides to Present COVID-19 Drug Update at The LD 500 Virtual Conference. SHELTON, CT / ACCESSWIRE / September 2, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 8:20 AM PDT / 11:20 AM EDT. Anil R. Diwan, PhD, President and Executive Chairman of the Company, will be presenting to a live audience. . You can read further details here
NanoViricides Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $19.20 on 01/31/20, with the lowest value was $2.25 for the same time period, recorded on 01/09/20.
NanoViricides Inc. (NNVC) full year performance was 31.91%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, NanoViricides Inc. shares are logging -70.94% during the 52-week period from high price, and 338.92% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.27 and $19.20.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 15050819 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the NanoViricides Inc. (NNVC) recorded performance in the market was 122.31%, having the revenues showcasing -20.29% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 55.41M, as it employees total of 17 workers.
Market experts do have their say about NanoViricides Inc. (NNVC)
During the last month, 0 analysts gave the NanoViricides Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.68, with a change in the price was noted -0.14. In a similar fashion, NanoViricides Inc. posted a movement of -2.45% for the period of last 100 days, recording 1,314,333 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NNVC is recording 0.08 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of NanoViricides Inc. (NNVC)
Raw Stochastic average of NanoViricides Inc. in the period of last 50 days is set at 30.97%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 69.61%. In the last 20 days, the company’s Stochastic %K was 31.10% and its Stochastic %D was recorded 19.00%.
Bearing in mind the latest performance of NanoViricides Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 122.31%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -30.94%, alongside a boost of 31.91% for the period of the last 12 months. The shares increased approximately by 44.19% in the 7-day charts and went up by -10.58% in the period of the last 30 days. Common stock shares were lifted by -20.29% during last recorded quarter.